Clinical and translational research

A key aim in Edinburgh is to move infection research from the bench to the bedside, engaging with the clinical community both in Edinburgh and in overseas countries to prioritise, the most effective laboratory research to solve pressing global health problems.

Developing novel therapeutics for infection and inflammation - Peter Barlow

Work in the Barlow lab at Edinburgh Napier University focuses on exploiting Cationic Host Defence Peptides as novel therapeutic agents to treat infection and inflammation.

Lighting up the Lung to treat infection - the Proteus Project

The Proteus project is a flagship research consortium led by Kev Dhaliwal (Centre for Inflammation Research) and Mark Bradley (School of Chemistry) aiming to developing a novel imaging based point-of-care diagnostic for pulmonary infection.

Biochip development for personalised medicine - Till Bachmann

Research in the Bachmann group combines biochip development with genomics research for the next achievements in personalised medicine in infectious diseases.